New Cellular Backup Pathway for Cysteine Production Could Target Cancer Resistance

Scientists have uncovered a previously unknown backup system that allows mammalian cells to synthesize the essential amino acid cysteine even when the main, once‑indispensable pathways are disabled. The discovery reveals that cells possess an alternative route to maintain cysteine levels, a critical component for protein synthesis and redox balance. Importantly, the same survival mechanism may be exploited by cancer cells to withstand therapeutic attacks. By targeting this backup pathway, researchers could potentially render tumors more vulnerable to existing treatments, offering a novel strategy to overcome drug resistance in cancer therapy.